Skip to main content
Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-Analysis
Published Web Location
https://doi.org/10.3390/cancers17030390Abstract
Over the last two decades, tumor necrosis factor-alpha inhibitors (TNF-Is) have become standard therapies for chronic inflammatory disorders, with an ongoing expansion of indications and off-label applications [...].
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.